Late Effects After Primary Therapy For Hl

It is now known that secondary malignancies are a serious and potentially lethal consequence of primary HLe therapy. The combination of death from secondary malignancies and posttreatment cardiac mortality may result in more deaths for patients with favorable limited stage HL than does the HL itself.

Table 73.4 shows a summary of recently reported large studies examining the risk of secondary malignancies in patients who received therapy for HL. The vast majority of patients described in these studies received

Table 73.4


malignancy after HL therapy

0 0

Post a comment